CareDx Launches Olerup QTYPE® at ASHI
During a lunchtime symposium on the pre-to-post transplant continuum,
John Lunz, PhD, from the
Daniel Brennan, MD from the
Olerup QTYPE is a robust and easy to use alternative for rapid HLA typing within one hour. This new test brings several needed features to HLA labs, including speed and precision.
Olerup QTYPE is currently for use on the Roche LightCycler 480II, a robust and well established
RT-PCR instrument. Validation studies are also underway for the use of Olerup QTYPE on the ABI suite of instruments. Multiple product demonstrations have been scheduled at several HLA laboratories across the US and
Olerup QTYPE is the first product to launch following the acquisition of
Peter Maag, President and CEO of CareDx. "This new product allows us to build on our expertise and leadership across transplantation."
Forward Looking Statements
In addition to historical information, this press release contains forward-looking statements with respect to our business, research, development and commercialization efforts and anticipated future financial results. These forward-looking statements are based upon information that is currently available to us and our current expectations, speak only as of the date hereof, and are subject to numerous risks and uncertainties that are described in our filings with the